NVAX – Novavax, Inc.
Novavax, Inc.NVAX
$6.56Name : Novavax, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,062,523,200.00
EPSttm : 2.75
Novavax, Inc.
$6.56
1.35%$0.09Float Short %
29.2
Margin Of Safety %
Put/Call OI Ratio
0.72
EPS Next Q Diff
-3.15
EPS Last/This Y
3.64
EPS This/Next Y
-2.22
Price
6.56
Target Price
13.29
Analyst Recom
2.71
Performance Q
2.34
Relative Volume
0.67
Beta
2.5
Ticker: NVAX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | NVAX | 6.79 | 0.64 | 0.37 | 374509 |
| 2025-07-07 | NVAX | 6.58 | 0.64 | 0.25 | 368738 |
| 2025-07-08 | NVAX | 7.04 | 0.64 | 0.15 | 370796 |
| 2025-07-09 | NVAX | 7.03 | 0.63 | 0.23 | 375356 |
| 2025-07-10 | NVAX | 7.09 | 0.63 | 0.12 | 376086 |
| 2025-07-11 | NVAX | 6.84 | 0.63 | 0.20 | 378500 |
| 2025-07-14 | NVAX | 6.97 | 0.65 | 0.07 | 371078 |
| 2025-07-15 | NVAX | 6.89 | 0.64 | 0.16 | 373435 |
| 2025-07-16 | NVAX | 6.95 | 0.64 | 0.16 | 374736 |
| 2025-07-17 | NVAX | 7 | 0.64 | 0.80 | 376108 |
| 2025-07-18 | NVAX | 7.01 | 0.60 | 0.15 | 352508 |
| 2025-07-21 | NVAX | 7.18 | 0.83 | 0.22 | 266308 |
| 2025-07-22 | NVAX | 7.22 | 0.82 | 0.08 | 270840 |
| 2025-07-23 | NVAX | 7.83 | 0.78 | 0.05 | 279572 |
| 2025-07-24 | NVAX | 7.64 | 0.71 | 0.14 | 299522 |
| 2025-07-25 | NVAX | 7.47 | 0.69 | 0.16 | 313066 |
| 2025-07-28 | NVAX | 7.28 | 0.76 | 0.16 | 294038 |
| 2025-07-29 | NVAX | 7.01 | 0.75 | 0.31 | 297435 |
| 2025-07-30 | NVAX | 6.84 | 0.75 | 0.18 | 300303 |
| 2025-07-31 | NVAX | 6.64 | 0.74 | 0.07 | 303468 |
| 2025-08-01 | NVAX | 6.57 | 0.72 | 0.19 | 308207 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | NVAX | 6.80 | -120.2 | - | 2.56 |
| 2025-07-07 | NVAX | 6.61 | -120.2 | - | 2.56 |
| 2025-07-08 | NVAX | 7.04 | -120.2 | - | 2.56 |
| 2025-07-09 | NVAX | 7.04 | -120.2 | - | 2.56 |
| 2025-07-10 | NVAX | 7.10 | -120.2 | - | 2.56 |
| 2025-07-11 | NVAX | 6.84 | -120.2 | - | 2.56 |
| 2025-07-14 | NVAX | 6.97 | -120.2 | - | 2.56 |
| 2025-07-15 | NVAX | 6.88 | -120.2 | - | 2.56 |
| 2025-07-16 | NVAX | 6.95 | -120.2 | - | 2.56 |
| 2025-07-17 | NVAX | 7.00 | -120.2 | - | 2.56 |
| 2025-07-18 | NVAX | 7.01 | -120.2 | - | 2.56 |
| 2025-07-21 | NVAX | 7.18 | -120.2 | - | 2.56 |
| 2025-07-22 | NVAX | 7.23 | -120.2 | - | 2.56 |
| 2025-07-23 | NVAX | 7.84 | -120.2 | - | 2.56 |
| 2025-07-24 | NVAX | 7.64 | -111.2 | - | 2.41 |
| 2025-07-25 | NVAX | 7.47 | -111.2 | - | 2.41 |
| 2025-07-28 | NVAX | 7.30 | -111.2 | - | 2.41 |
| 2025-07-29 | NVAX | 7.01 | -111.2 | - | 2.41 |
| 2025-07-30 | NVAX | 6.85 | -111.2 | - | 2.41 |
| 2025-07-31 | NVAX | 6.65 | -111.2 | - | 2.41 |
| 2025-08-01 | NVAX | 6.56 | -111.2 | - | 2.41 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | NVAX | 0.00 | -4.89 | 30.15 |
| 2025-07-07 | NVAX | 0.00 | -4.92 | 30.15 |
| 2025-07-08 | NVAX | 0.00 | -4.92 | 30.15 |
| 2025-07-09 | NVAX | 0.00 | -4.92 | 30.15 |
| 2025-07-10 | NVAX | 0.00 | -4.92 | 30.15 |
| 2025-07-11 | NVAX | 0.00 | -4.92 | 31.56 |
| 2025-07-14 | NVAX | 0.00 | -4.74 | 31.56 |
| 2025-07-15 | NVAX | 0.00 | -4.74 | 31.56 |
| 2025-07-16 | NVAX | 0.00 | -4.74 | 31.56 |
| 2025-07-17 | NVAX | 0.00 | -4.74 | 31.56 |
| 2025-07-18 | NVAX | 0.00 | -4.74 | 31.55 |
| 2025-07-21 | NVAX | 0.00 | -4.70 | 31.55 |
| 2025-07-22 | NVAX | 0.00 | -4.70 | 31.55 |
| 2025-07-23 | NVAX | 0.00 | -4.70 | 31.55 |
| 2025-07-24 | NVAX | 0.00 | -4.70 | 31.55 |
| 2025-07-25 | NVAX | 0.00 | -4.70 | 29.20 |
| 2025-07-28 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-07-29 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-07-30 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-07-31 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-08-01 | NVAX | 0.00 | -4.79 | 29.20 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.93
Avg. EPS Est. Current Quarter
-0.05
Avg. EPS Est. Next Quarter
-0.22
Insider Transactions
Institutional Transactions
-4.79
Beta
2.5
Average Sales Estimate Current Quarter
147
Average Sales Estimate Next Quarter
89
Fair Value
Quality Score
96
Growth Score
32
Sentiment Score
4
Actual DrawDown %
98
Max Drawdown 5-Year %
-98.8
Target Price
13.29
P/E
2.47
Forward P/E
147.78
PEG
0.06
P/S
0.85
P/B
P/Free Cash Flow
EPS
2.65
Average EPS Est. Cur. Y
2.41
EPS Next Y. (Est.)
0.2
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
38.14
Relative Volume
0.67
Return on Equity vs Sector %
-656.6
Return on Equity vs Industry %
-637.9
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.14
EBIT Estimation
Novavax, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 952
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading